Efeitos cardiovasculares de duas doses de dexmedetomidina: estudo experimental em cães
Cardiovascular effects of two dexmedetomidine doses: experimental study in dogs
Nivaldo Ribeiro Villela; Paulo do Nascimento Júnior; Lídia Raquel de Carvalho
Resumo
Palavras-chave
Abstract
Keywords
References
Udelsman R, Norton JA, Jelenich SE. Responses of the hypothalamic-pituitary-adrenal and renin-angiotensin axes and the sympathetic system during controlled surgical and anesthetic stress. J Clin Endocrinol. 1987;64:986-994.
Oliver MF, Goldman L, Julian DG. Effects of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European mivazerol trial (RMIT). Anesthesiology. 1999;91:951-961.
Hayashi Y, Maze M. Alpha2 adrenoceptor agonists and anaesthesia. Br J Anaesth. 1993;71:108-118.
Karol MD, Maze M. Pharmacokinetics and interaction pharmacodynamics of dexmedetomidine in humans. Baillières Clin Anesthesiol. 2000;14:261-269.
Doze VA, Chen BX, Maze M. Dexmedetomidine produces a hypnotic-anesthetic action an rats via activation of alpha2-adrenoceptors. Anesthesiology. 1989;71:75-79.
Nguyen D, Abdul-Rasool I, Ward D. Ventilatory effects of dexmedetomidine, atipamezole, and isoflurane in dogs. Anesthesiology. 1992;76:573-579.
Scheinin M, Kallio A, Koulu M. Sedative and cardiovascular effects of medetomidine, a novel selective alpha2 adrenoceptor agonist, in healthy volunteers. Br J Clin Pharmacol. 1987;4:443-451.
Kallio A, Scheinin M, Koulu M. Effects of dexmedetomidine, a selective alpha2-adrenoceptor agonist, on hemodynamic control mechanisms. Clin Pharmacol Ther. 1989;46:33-42.
Ebert TJ, Hall JE, Barney JA et al. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology. 2000;93:382-394.
Aho M, Scheinin M, Lehtinen AM. Intramuscularly administered dexmedetomidine attenuates hemodynamic and stress hormone responses to gynecologic laparoscopy. Anesth Analg. 1992;75:932-939.
Fragen RJ, Fitzgerald PC. Effect of dexmedetomidine on the minimum alveolar concentration (MAC) of sevoflurane in adult age 55 to 70 years. J Clin Anesth. 1999;11:466-470.
Nociti JR, Serzedo PSM, Zuccolotto EB. Dexmedetomidina associada a propofol em sedação durante anestesia local para cirurgia plástica. Rev Bras Anestesiol. 2003;53:198-208.
Aho M, Lehtnen AM, Erkola O. The effect of intravenously administered dexmedetomidine on perioperative hemodynamics and isoflurane requirements in patients undergoing abdominal hysterectomy. Anesthesiology. 1991;74:997-1002.
Curtis FG, Castiglia YMM, Stolf AA. Dexmedetomidina e sufentanil como analgésicos per-operatórios: Estudo comparativo. Rev Bras Anestesiol. 2002;52:525-534.
Talke P, Chen R, Thomas B. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg. 2000;90:834-839.
Venn RM, Bradshaw CJ, Spencer R. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia. 1999;54:1136-1142.
Aantaa R, Kallio A, Virtanen R. Dexmedetomidine, a novel alpha2-adrenergic agonist: A review of its pharmacodynamic characteristics. Drugs Future. 1993;18:49-56.
Villela NR, Nascimento Jr P. Uso de dexmedetomidina em Anestesiologia. Rev Bras Anestesiol. 2003;53:97-113.
Jones MEP, Maze M. Can we characterize the central nervous system action of alpha2-adrenergic agonists?. Br J Anaesth. 2001;86:1-3.
Massone F. Anestesiologia Veterinária. 1999.
Monk TG, Mueller M, White PF. Treatment of stress response during balanced anesthesia: Comparative effects of isoflurane, alfentanil and trimethaphan. Anesthesiology. 1992;76:39-45.
Vickery RG, Sheridon BC, Segal IS. Anesthetic and hemodynamic effects of the steroisomers of medetomidine, an alpha2-adrenergic agonist, in halothane-anesthetized dogs. Anesth Analg. 1988;67:611-615.
Flacke JW, Flacke WE, Bloor BC. Hemodynamic effects of dexmedetomidine, an alpha2-adrenergic agonist, in autonomically denervated dogs. J Cardiovasc Pharmacol. 1990;16:616-623.
Schmeling WT, Kampine JP, Roerig DL et al. The effects of stereoisomers of the alpha2-adrenergic agonist medetomidine on systemic and coronary hemodynamics in conscious dogs. Anesthesiology. 1991;75:499-511.
Bloor BC, Alper G, Frankland M. Nifedipine attenuates the acute hemodynamic changes that occur with intravenous dexmedetomidine in dogs. Anesth Analg. 1989;68:S32.
Dyck JB, Maze M, Haack C. The pharmacokinetics and hemodynamic effects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology. 1993;78:813-820.
Proctor LT, Schmeling WT, Roerig D et al. Oral dexmedetomidine attenuates hemodynamic responses during emergence from general anesthesia in chronically instrumented dogs. Anesthesiology. 1991;74:108-114.
Zornow MH. Ventilatory, hemodynamic and sedative effects of the alpha2-adrenergic agonist, dexmedetomidine. Neuropharmacology. 1991;30:1065-1071.
Oku S, Benson KT, Hirakawa M. Renal sympathetic nerve activity after dexmedetomidine in nerve-intact and baroreceptor-denervated rabbits. Anesth Analg. 1996;83:477-481.
Mroczek WJ, Davidov M, Finnerty FA. Intravenous clonidine in hypertensive patients. Clin Pharmacol Ther. 1973;14:847-851.
Reis DJ, Morrison S, Ruggiero DA. The C1 area of the brainstem in tonic and reflex control of the circulation. Hypertension. 1988;11:8-13.
Svennson TH, Bunney BS, Aghajanian GK. Inhibition of both noradrenergic and serotonergic neurons in brain by the alpha-adrenergic agonist clonidine. Brain Res. 1975;92:291-306.
Engelhard K, Werner C, Kaspar S. Effects of the alpha2-agonist dexmedetomidine on cerebral neurotransmitter concentrations during cerebral ischemia in rats. Anesthesiology. 2002;96:450-457.
Ebert TJ, Hall JE, Barney JA. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology. 2000;93:382-394.
Docherty JR. Subtypes of functional alpha1- and alpha2-adrenoceptors. Eur J Pharmacol. 1998;361:1-15.
Saunders C, Limbird LE. Localization and trafficking of alpha2-adrenergic receptor subtypes in cells and tissues. Pharmacol Ther. 1999;84:193-205.
Khan ZP, Furgson CN, Jones RM. Alpha-2 and imidazoline receptor agonists: Their pharmacology and therapeutic role. Anesthesia. 1999;54:146-165.
Kuusela E, Raekallio M, Anttila M. Clinical effects and pharmacokinetics of medetomidine and enantiomers in dogs. J Vet Pharmacol Therap. 2000;23:15-20.
Lawrence CJ, Prinzen FW, de Lange S. Comparison of the haemodynamic effects of the alpha-2 agonists clonidine and dexmedetomidine in the anaesthetized dog. J Cardiothorac Vasc Anesth. 1994;8:32.
Larach DR, Schuler HG, Derr JA. Halothane selectively attenuates alpha2-adrenoceptor mediated vasoconstriction, in vivo and in vitro. Anesthesiology. 1987;66:781-792.
Stevens WC, Cromwell TH, Hasey MJ. The cardiovascular effects of a new inhalation anesthetic, forane, in human volunteers at constant arterial carbon dioxide tension. Anesthesiology. 1971;35:8-16.